Inhibitory effects of adiponectin on platelet-derived growth factor-induced mesangial cell migration

Journal of Endocrinology

Volumn 202, Issue 2, 2009, Pages 309-316

  Ishizawa, Keisuke ^a   Dorjsuren, Narantungalag ^a   Izawa Ishizawa, Yuki ^a   Sugimoto, Rika ^a   Ikeda, Yasumasa ^a   Kihira, Yoshitaka ^a   Kawazoe, Kazuyoshi ^a   Tomita, Shuhei ^a   Tsuchiya, Koichiro ^a   Minakuchi, Kazuo ^a   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE; RECOMBINANT PROTEIN; SMALL INTERFERING RNA;

ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENETICS; MALE; MESANGIUM; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ADIPONECTIN; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLOMERULAR MESANGIUM; IMIDAZOLES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 7; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING;

EID: 70349242253     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0469     Document Type: Article

References (47)

1. Adhikary L, Chow F, Nikolic-Paterson DJ, Stambe C, Dowling J, Atkins RC & Tesch GH 2004 Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia 47 1210-1222.
2. Ali N, Yoshizumi M, Fujita Y, Izawa Y, Kanematsu Y, Ishizawa K, Tsuchiya K, Yano S, Sone S & Tamaki T 2005 A novel Src kinase inhibitor, M475271, inhibits VEGF-induced human umbilical vein endothelial cell proliferation and migration. Journal of Pharmacological Sciences 98 130-141.
3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K et al. 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257 79-83.
4. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M et al. 2002 Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 2893-2898.
5. Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakane T, Kodera K, Shirahata A & Taniyama M 2003 Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obesity Research 11 1072-1079.
6. Bagchus WM, Jeunink MF & Elema JD 1990 The mesangium in anti-Thy-1 nephritis. Influx of macrophages, mesangial cell hypercellularity, and macromolecular accumulation. American Journal of Pathology 137 215-223.
7. Barros JC & Marshall CJ 2005 Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton. Journal of Cell Science 118 1663-1671.
8. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK & He J 2004 The metabolic syndrome and chronic kidney disease in US adults. Annals of Internal Medicine 140 167-174.
9. Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M & Rimm EB 2001 Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 157 495-503.
10. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG & Johnson RJ 1992 Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney International 41 297-309.
11. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF & Johnson RJ 1993 Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. Journal of Clinical Investigation 92 2952-2962.
12. Gross ML, Ritz E, Schoof A, Adamczak M, Koch A, Tulp O, Parkman A, El-Shakmak A, Szabo A & Amann K 2004 Comparison of renal morphology in the streptozotocin and the SHR/N-cp models of diabetes. Laboratory Investigation 84 452-464.
13. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A & Fouque D 2005 Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrology, Dialysis, Transplantation 20 129-134.
14. Harper L, Kashiwagi Y, Pusey CD, Hendry BM & Domin J 2007 Platelet-derived growth factor reorganizes the actin cytoskeleton through 3-phosphoinositide-dependent and 3-phosphoinositide-independent mechanisms in human mesangial cells. Nephron. Physiology 107 p45-p56.
15. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K et al. 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 20 1595-1599.
16. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T & Imai E 1993 Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. Journal of Clinical Investigation 92 2597-2601.
17. Ishizawa K, Yoshizumi M, Tsuchiya K, Houchi H, Minakuchi K, Izawa Y, Kanematsu Y, Kagami S, Hirose M & Tamaki T 2004 Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells. Hypertension Research 27 433-440.
18. Izawa Y, Yoshizumi M, Ishizawa K, Fujita Y, Kondo S, Kagami S, Kawazoe K, Tsuchiya K, Tomita S & Tamaki T 2007 Big mitogen-activated protein kinase1 (BMK1)/ERK5 is involved in platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration. Hypertension Research 30 1107-1117.
19. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K & Tobe K 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 116 1784-1792.
20. Kagami S, Kondo S, Loster K, ReutterW, Kuhara T, Yasutomo K & Kuroda Y 1999 Alpha1beta1 integrin-mediated collagen matrix remodeling by rat mesangial cells is differentially regulated by transforming growth factor-beta and platelet-derived growth factor-BB. Journal of the American Society of Nephrology 10 779-789.
21. Kagami S, Urushihara M, Kitamura A, Kondo S, Hisayama T, Kitamura M, Loster K, Reutter W & Kuroda Y 2004 PDGF-BB enhances alpha1beta1 integrin-mediated activation of the ERK/AP-1 pathway involved in collagen matrix remodeling by rat mesangial cells. Journal of Cellular Physiology 198 470-478.
22. Karihaloo A, O'Rourke DA, Nickel C, Spokes K & Cantley LG 2001 Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis. Journal of Biological Chemistry 276 9166-9173.
23. Kohno M, Yasunari K, Minami M, Kano H, Maeda K, Mandal AK, Inoki K, Haneda M & Yoshikawa J 1999 Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin. Journal of the American Society of Nephrology 10 2495-2502.
24. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H et al. 2002 Disruption of adiponectin causes insulin resistance and neointimal formation. Journal of Biological Chemistry 277 25863-25866.
25. Kurella M, Lo JC & Chertow GM 2005 Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Journal of the American Society of Nephrology 16 2134-2140.
26. Lali FV, Hunt AE, Turner SJ & Foxwell BM 2000 The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. Journal of Biological Chemistry 275 7395-7402.
27. Lee JD, Ulevitch RJ & Han J 1995 Primary structure of BMK1: a new mammalian map kinase. Biochemical and Biophysical Research Communications 213 715-724.
28. Lorenzo C, Okoloise M, Williams K, Stern MP & Haffner SM 2003 The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26 3153-3159.
29. De Marchi S, Falleti E, Giacomello R, Stel G, Cecchin E, Sepiacci G, Bortolotti N, Zanello F, Gonano F & Bartoli E 1996 Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. Journal of the American Society of Nephrology 7 1169-1177.
30. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H et al. 2002 Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. Journal of Biological Chemistry 277 37487-37491.
31. Motobayashi Y, Izawa-Ishizawa Y, Ishizawa K, Orino S, Yamaguchi K, Kawazoe K, Hamano S, Tsuchiya K, Tomita S & Tamaki T 2009 Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells. Hypertension Research 32 188-193.
32. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A & Chen RS 2004 Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109 42-46.
33. Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, Hough K, Scalia R & Goldstein BJ 2006 Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55 1840-1846.
34. Pang C, Gao Z, Yin J, Zhang J, Jia W & Ye J 2008 Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. American Journal of Physiology. Endocrinology and Metabolism 295 E313-E322.
35. Pellme F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR & Jansson PA 2003 Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 52 1182-1186.
36. Pi X, Yan C & Berk BC 2004 Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circulation Research 94 362-369.
37. Sowers JR, Epstein M & Frohlich ED 2001 Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37 1053-1059.
38. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimburger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M et al. 2004 Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney International 65 274-281.
39. Striker LJ, Doi T, Elliot S & Striker GE 1989 The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Seminars in Nephrology 9 318-328.
40. Suzaki Y, Yoshizumi M, Kagami S, Nishiyama A, Ozawa Y, Kyaw M, Izawa Y, Kanematsu Y, Tsuchiya K & Tamaki T 2004 BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kidney International 65 1749-1760.
41. Takeuchi Y, Yamauchi K, Nakamura J, Shigematsu S & Hashizume K 2006 Angiotensin II regulates migration in mouse cultured mesangial cells: evidence for the presence of receptor subtype-specific regulation. Journal of Endocrinology 191 361-367.
42. Tozawa M, Iseki C, Tokashiki K, Chinen S, Kohagura K, Kinjo K, Takishita S & Iseki K 2007 Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertension Research 30 937-943.
43. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J et al. 2004 Obesity and the metabolic syndrome in children and adolescents. New England Journal of Medicine 350 2362-2374.
44. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 86 1930-1935.
45. Yamaguchi H, Igarashi M, Hirata A, Sugae N, Tsuchiya H, Jimbu Y, Tominaga M & Kato T 2004 Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta. Arteriosclerosis, Thrombosis, and Vascular Biology 24 2095-2101.
46. Yaturu S, Reddy RD, Rains J & Jain SK 2007 Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine 37 1-5.
47. Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H & Iwao H 2003 Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arteriosclerosis, Thrombosis, and Vascular Biology 23 795-801.